Arani Chatterjee

Immunogenicity of bivalent types 1 and 3 oral poliovirus vaccine: a randomised, double-blind, controlled trial

Roland W. Sutter, T. Jacob John, Hemant Jain et al. · The Lancet · 2010 · 142 citations

Vaccination, Cell-based Vaccine Production, Vaccine Safety +9

Immunogenicity of supplemental doses of poliovirus vaccine for children aged 6–9 months in Moradabad, India: a community-based, randomised controlled trial

Concepción F. Estívariz, Hamid Jafari, Roland W. Sutter et al. · The Lancet Infectious Diseases · 2011 · 98 citations

Vaccination, Vaccine Safety, Vaccinology +11

Immunogenicity of a new routine vaccination schedule for global poliomyelitis prevention: an open-label, randomised controlled trial

Roland W. Sutter, Sunil Bahl, Jagadish M. Deshpande et al. · The Lancet · 2015 · 64 citations

Vaccination, Vaccine Safety, Preventive Medicine +8

Monovalent type 1 oral poliovirus vaccine among infants in India: Report of two randomized double-blind controlled clinical trials

T. Jacob John, Hemant Jain, Ravishankar Kanithi et al. · Vaccine · 2011 · 24 citations

Vaccination, Vaccine Safety, Vaccinology +10

Safety, Tolerability, and Pharmacokinetics of a Capsule Formulation of DRF‐1042, a Novel Camptothecin Analog, in Refractory Cancer Patients in a Bridging Phase I Study

Arani Chatterjee, Raghunadharao Digumarti, Kasiram Katneni et al. · The Journal of Clinical Pharmacology · 2005 · 18 citations · Full text

Medicinal Chemistry, Oncology, Refractory Cancer Patients +13